Introduction to Codexis
Codexis is a leading developer of biocatalytic chemical processes that can dramatically reduce manufacturing costs across a broad range of industries. Our proprietary technology enables novel solutions for cost-effective, efficient, and environmentally sound production of pharmaceuticals, transportation fuels, and industrial chemicals. Our focus is on improving R&D productivity for our partners while significantly reducing their capital expenditures and cost-of-goods using green chemistry Close
Green ChemistryDesign of chemical products and processes that reduce or eliminate the use and generation of hazardous substancesmethods.
The privately held company was formed in 2002 and has raised more than $72 million in private equity from leading industry investors. Investors include Bio*One Capital, Chevron Technology Ventures, CMEA, Maxygen, Pequot and Pfizer.
Codexis headquarters, located in Redwood City, California, house research and development, corporate offices, and a process scale-up and launch center. Codexis also maintains facilities in the United States, Germany, Hungary and Singapore, and a sales subsidiary in India.
Since its inception, Codexis has entered into strategic alliances with some of the world's leading companies, including Merck, Pfizer, Schering-Plough, Teva and Shell. Codexis serves partners through two business units, Pharmaceuticals and Bioindustrials.
- Codexis Pharmaceuticals serves global leaders in the innovator and generics sectors of the pharmaceutical industry worldwide through the Pharma Services group and the Generics group. Pharma Services markets custom biocatalytic chemical processes and services to innovator pharmaceutical companies. Generics focuses on manufacturing and direct sales of pharmaceutical intermediates and active pharmaceutical ingredients CloseActive Pharmaceutical Ingredient (API)The pharmaceutically active substance (molecule) in a drug.(APIs) for the generics industry.
- Codexis Bioindustrials serves major worldwide markets where clean technology can make a significant economic and environmental impact. Codexis is developing biocatalytic processes for the energy, environmental and chemicals markets focused on cost-effective conversion of renewable resources into transportation fuels and industrial chemicals and on development of new technologies for effective air and water treatment.